ArticleTrials2024

A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteers.

Vanessa Meier-Stephenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.